Results of a study found patients who received maintenance therapy with rituximab following autologous stem cell transplantation as treatment for mantle cell lymphoma had a survival advantage.
Home / Resource Library / Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab